53 results
8-K
EX-99.1
TOVX
Theriva Biologics Inc
16 Apr 24
Regulation FD Disclosure
8:00am
indications FINANCIAL AND INVESTMENT GOALS
34 SEASONED LEADERSHIP TEAM Manel Cascall ó PhD General Director, EU Subsidiary Expertise in oncolytic
8-K
EX-99.1
TOVX
Theriva Biologics Inc
8 Jan 24
Regulation FD Disclosure
8:10am
AND INVESTMENT GOALS
APPENDIX
18 SEASONED LEADERSHIP TEAM Manel Cascall ó PhD General Director, EU Subsidiary Expertise in oncolytic adenovirus clinical
DEFR14A
TOVX
Theriva Biologics Inc
16 Aug 23
Revised proxy
5:24pm
issues facing pharmaceutical companies. His healthcare experience, executive and leadership experience further qualify him as a member of the Board … in the pharmaceutical and medical industries. He has extensive business, managerial, executive and leadership experience that further qualify him
8-K
EX-99.1
08m63v
16 May 22
Synthetic Biologics Reports First Quarter 2022 Operational Highlights and Financial Results
8:05am
8-K
EX-99.1
ppqel
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
DEFR14A
ju3 fu18mmqje7uubu3
17 Aug 21
Revised proxy
4:31pm
8-K
EX-99.1
yxpj8fur
4 Mar 21
Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results
4:15pm
8-K
EX-99.1
ddlh9sbu exerwgb4
12 Nov 20
Departure of Directors or Certain Officers
7:05am